{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T19:42:33Z","timestamp":1782330153645,"version":"3.54.5"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Small cohort studies have shown rapid pleurodesis protocol's (RPP) effectiveness and capacity to expedite pleurodesis for malignant pleural effusion (MPE). This study intends to evaluate the effectiveness of the RPP in inducing pleurodesis in patients with pleural effusions from either malignant or benign etiologies.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>In this single-center, retrospective cohort study spanning 2 decades, we assessed patients with recurrent symptomatic chronic noninfectious pleural effusion, both benign and malignant. Post-RPP, chest tubes were removed when fluid output dropped below 150\u00a0mL\/d, and patients were discharged with daily indwelling pleural catheter (IPC) drainage. Exclusion criteria included nonexpandable lung and active pleural infection. Treatment success was defined as IPC removal on reduced output (&lt;50\u00a0mL) on 3 consecutive drainages and radiologic effusion resolution. Recurrence was defined as the occurrence of pleural effusion requiring additional pleural procedures postsuccess. Duration outcome was expressed as median with IPC placement as time zero.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Of the 210 patients studied, 72% had MPE, and 28% had benign effusions. The median hospital stay was 4 days post-RPP. Treatment was successful in 177 (84%) patients within a median of 12 days, with no significant differences between MPE and benign cases. Nine patients (5%) experienced recurrence within a median of 152 days. Complications included hemothorax in 4 (1.9%) and empyema in 2 (1%). The thirty-day mortality rate was 9%, with a median survival time of 245 days postprocedure.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>The RPP combines the benefit of chemical pleurodesis and IPC and appears to be a reasonable option for patients with recurrent and symptomatic pleural effusion.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/lbr.0000000000000993","type":"journal-article","created":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T17:11:49Z","timestamp":1730308309000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Rapid Pleurodesis in Patients With Chronic Noninfectious Pleural Effusion"],"prefix":"10.1097","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0012-7955","authenticated-orcid":false,"given":"Chan Yeu","family":"Pu","sequence":"first","affiliation":[{"name":"Division of Thoracic Surgery and Interventional Pulmonology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA"},{"name":"Division of Pulmonary, Critical Care and Sleep Medicine, St. Elizabeth\u2019s Medical Center, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilo A.","family":"Avendano","sequence":"additional","affiliation":[{"name":"Division of Thoracic Surgery and Interventional Pulmonology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makayla","family":"Durant","sequence":"additional","affiliation":[{"name":"Division of Thoracic Surgery and Interventional Pulmonology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Ospina-Delgado","sequence":"additional","affiliation":[{"name":"Division of Thoracic Surgery and Interventional Pulmonology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA"},{"name":"Johns Hopkins Bloomberg School of Public Health, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alma V.","family":"Burbano","sequence":"additional","affiliation":[{"name":"Division of Thoracic Surgery and Interventional Pulmonology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai E.","family":"Swenson","sequence":"additional","affiliation":[{"name":"Division of Thoracic Surgery and Interventional Pulmonology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Beattie","sequence":"additional","affiliation":[{"name":"Division of Thoracic Surgery and Interventional Pulmonology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihir","family":"Parikh","sequence":"additional","affiliation":[{"name":"Division of Thoracic Surgery and Interventional Pulmonology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adnan","family":"Majid","sequence":"additional","affiliation":[{"name":"Division of Thoracic Surgery and Interventional Pulmonology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,1]]},"reference":[{"key":"R1-20241030","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1183\/09031936.93.02040366","article-title":"Pleural metastatic tumours and effusions. Frequency and pathogenic mechanisms in a post-mortem series","volume":"2","author":"Rodriguez-Panadero","year":"1989","journal-title":"Eur Respir J"},{"issue":"suppl 2","key":"R2-20241030","doi-asserted-by":"crossref","first-page":"ii32","DOI":"10.1136\/thx.2010.136994","article-title":"Management of a malignant pleural effusion: British Thoracic Society pleural disease guideline 2010","volume":"65","author":"Roberts","year":"2010","journal-title":"Thorax"},{"key":"R3-20241030","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1164\/rccm.201807-1415ST","article-title":"Management of malignant pleural effusions. An official ATS\/STS\/STR Clinical Practice Guideline","volume":"198","author":"Feller-Kopman","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"R4-20241030","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.athoracsur.2013.03.063","article-title":"A Propensity-matched comparison of pleurodesis or tunneled pleural catheter in patients undergoing diagnostic thoracoscopy for malignancy","volume":"96","author":"Freeman","year":"2013","journal-title":"Ann Thorac Surg"},{"key":"R5-20241030","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1177\/1479972311407216","article-title":"The use of the PleurX catheter in the management of non-malignant pleural effusions","volume":"8","author":"Chalhoub","year":"2011","journal-title":"Chron Respir Dis"},{"key":"R6-20241030","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1001\/jama.2012.5535","article-title":"Effect of an indwelling pleural catheter vs vhest tube and talc pleurodesis for relieving dyspnea in patients with malignant leural effusion: the TIME2 randomized controlled trial","volume":"307","author":"Davies","year":"2012","journal-title":"JAMA"},{"key":"R7-20241030","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1001\/jama.2017.17426","article-title":"Effect of an indwelling pleural catheter as talc oleurodesis on hospitalization days in patients with malignant pleural effusion: the AMPLE randomized clinical trial","volume":"318","author":"Thomas","year":"2017","journal-title":"JAMA"},{"key":"R8-20241030","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0003-4975(99)01482-4","article-title":"Outpatient management of malignant pleural effusion by a chronic indwelling pleural catheter","volume":"69","author":"Putnam","year":"2000","journal-title":"Ann Thorac Surg"},{"key":"R9-20241030","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s11606-010-1472-0","article-title":"Efficacy and safety of tunneled pleural catheters in adults with malignant pleural effusions: a systematic review","volume":"26","author":"Van Meter","year":"2011","journal-title":"J Gen Intern Med"},{"key":"R10-20241030","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1164\/rccm.201607-1404OC","article-title":"Randomized trial of pleural fluid grainage frequency in patients with malignant pleural effusions. The ASAP trial","volume":"195","author":"Wahidi","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"R11-20241030","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1001\/jama.2015.16840","article-title":"Effect of opioids vs NSAIDs and larger vs smaller chest tube size on pain control and pleurodesis efficacy among patients with malignant pleural wffusion: the TIME1 randomized clinical trial","volume":"314","author":"Rahman","year":"2015","journal-title":"JAMA"},{"key":"R12-20241030","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1001\/jama.2019.19997","article-title":"Effect of thoracoscopic talc poudrage vs talc slurry via chest tube on pleurodesis failure rate among patients with malignant pleural effusions","volume":"323","author":"Bhatnagar","year":"2020","journal-title":"JAMA"},{"key":"R13-20241030","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1378\/chest.10-1868","article-title":"Rapid pleurodesis for malignant pleural effusions","volume":"139","author":"Reddy","year":"2011","journal-title":"Chest"},{"key":"R14-20241030","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1056\/NEJMoa1716883","article-title":"Outpatient talc administration by indwelling pleural catheter for malignant effusion","volume":"378","author":"Bhatnagar","year":"2018","journal-title":"N Engl J Med"},{"key":"R15-20241030","doi-asserted-by":"crossref","first-page":"e001682","DOI":"10.1136\/bmjresp-2023-001682","article-title":"The randomised thoracoscopic talc poudrage+indwelling pleural catheters versus thoracoscopic talc poudrage only in malignant pleural effusion trial (TACTIC): study protocol for a randomised controlled trial","volume":"10","author":"Dipper","year":"2023","journal-title":"BMJ Open Respir Res"},{"key":"R17-20241030","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1510\/icvts.2009.222273","article-title":"Ultrasound estimation of volume of postoperative pleural effusion in cardiac surgery patients","volume":"10","author":"Usta","year":"2010","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"R18-20241030","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/00005382-199904000-00011","article-title":"New formula for quantification of pleural effusions from computed tomography","volume":"14","author":"Mergo","year":"1999","journal-title":"J Thorac Imaging"},{"key":"R19-20241030","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1136\/thoraxjnl-2014-205285","article-title":"Predicting survival in malignant pleural effusion: development and validation of the LENT prognostic score","volume":"69","author":"Clive","year":"2014","journal-title":"Thorax"},{"key":"R20-20241030","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.21037\/jtd.2016.08.55","article-title":"Patient evaluation for rapid pleurodesis of malignant pleural effusions","volume":"8","author":"Krochmal","year":"2016","journal-title":"J Thorac Dis"},{"key":"R21-20241030","doi-asserted-by":"crossref","first-page":"e87060","DOI":"10.1371\/journal.pone.0087060","article-title":"Efficacy and safety of talc pleurodesis for malignant pleural effusion: a meta-analysis","volume":"9","author":"Xia","year":"2014","journal-title":"PLoS One"},{"key":"R22-20241030","first-page":"CD010529","article-title":"Interventions for the management of malignant pleural effusions: a network meta-analysis","volume":"2016","author":"Clive","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"R23-20241030","first-page":"CD010529","article-title":"Interventions for the management of malignant pleural effusions: a network meta-analysis","volume":"4","author":"Dipper","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"R24-20241030","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S2213-2600(18)30288-1","article-title":"Aggressive versus symptom-guided drainage of malignant pleural effusion via indwelling pleural catheters (AMPLE-2): an open-label randomised trial","volume":"6","author":"Muruganandan","year":"2018","journal-title":"Lancet Respir Med"},{"key":"R25-20241030","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1002\/(SICI)1097-0142(19991115)86:10<1992::AID-CNCR16>3.0.CO;2-M","article-title":"A randomized comparison of indwelling pleural catheter and doxycycline pleurodesis in the management of malignant pleural effusions","volume":"86","author":"Putnam","year":"1999","journal-title":"Cancer"},{"key":"R26-20241030","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.21037\/jtd.2020.03.57","article-title":"Multimodal approach to the management of malignant pleural effusions: role of thoracoscopy with pleurodesis and tunneled indwelling pleural catheters","volume":"12","author":"Agrawal","year":"2020","journal-title":"J Thorac Dis"},{"key":"R27-20241030","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1097\/JTO.0b013e31820d614f","article-title":"Palliation and pleurodesis in malignant pleural effusion: the role for tunneled pleural catheters","volume":"6","author":"Suzuki","year":"2011","journal-title":"J Thorac Oncol"},{"key":"R28-20241030","doi-asserted-by":"crossref","first-page":"738719","DOI":"10.3389\/fsurg.2021.738719","article-title":"Ambulatory thoracoscopic pleurodesis combined with indwelling pleural catheter in malignant pleural effusion","volume":"8","author":"Foo","year":"2021","journal-title":"Front Surg [Internet]"},{"key":"R29-20241030","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/LBR.0000000000000186","article-title":"Pleuroscopic pleurodesis combined with tunneled pleural catheter for management of malignant pleural effusion: a prospective observational study","volume":"22","author":"Boujaoude","year":"2015","journal-title":"J Bronchol Interv Pulmonol"},{"key":"R30-20241030","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1080\/17476348.2020.1746647","article-title":"Predictors of outcome of pleurodesis in patients with malignant pleural effusion: a systematic review and meta-analysis","volume":"14","author":"Hassan","year":"2020","journal-title":"Expert Rev Respir Med"},{"key":"R31-20241030","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.lungcan.2008.02.017","article-title":"Predictors of talc pleurodesis outcome in patients with malignant pleural effusions","volume":"62","author":"Yildirim","year":"2008","journal-title":"Lung Cancer"},{"key":"R32-20241030","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.chest.2016.10.052","article-title":"Management of benign pleural effusions using indwelling pleural catheters: a systematic review and meta-analysis","volume":"151","author":"Patil","year":"2017","journal-title":"Chest"},{"key":"R33-20241030","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1513\/AnnalsATS.201507-471BC","article-title":"Tunneled pleural catheter placement with and without talc poudrage for treatment of pleural effusions due to congestive heart failure","volume":"13","author":"Majid","year":"2016","journal-title":"Ann Am Thorac Soc"},{"key":"R34-20241030","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/LBR.0000000000000192","article-title":"Management of malignant pleural effusion: a cost-utility analysis","volume":"22","author":"Shafiq","year":"2015","journal-title":"J Bronchol Interv Pulmonol"},{"key":"R35-20241030","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.athoracsur.2012.02.100","article-title":"Treatment of malignant pleural effusion: a cost-effectiveness analysis","volume":"94","author":"Puri","year":"2012","journal-title":"Ann Thorac Surg"},{"key":"R36-20241030","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1378\/chest.127.3.909","article-title":"Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion","volume":"127","author":"Dresler","year":"2005","journal-title":"Chest"}],"container-title":["Journal of Bronchology &amp; Interventional Pulmonology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/LBR.0000000000000993","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T17:11:59Z","timestamp":1730308319000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/LBR.0000000000000993"}},"subtitle":["Twenty Years of Real-world Performance Data"],"short-title":[],"issued":{"date-parts":[[2024,10,30]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/lbr.0000000000000993","relation":{},"ISSN":["1948-8270"],"issn-type":[{"value":"1948-8270","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,30]]},"assertion":[{"value":"2024-05-28","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-09-24","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}